A review of drug therapy for sporadic fatal insomnia

REFERENCES

• Lugaresi E, Medori R, Montagna P, Baruzzi A, Cortelli P, Lugaresi A, Tinuper P, Zucconi M, Gambetti P. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. New England J of Med. 1986;315:997–1003. doi:10.1056/NEJM198610163151605.
   PubMed Web of Science ®Google Scholar
• Alpers MP. The epidemiology of kuru: monitoring the epidemic from its peak to its end. Philos Trans R Soc Lond B Biol Sci. 2008;363(1510):3707–17. doi:10.1098/rstb.2008.0071. PMID:18849286.
   PubMed Web of Science ®Google Scholar
• McCutcheon S, Alejo Blanco AR, Houston EF, de Wolf C, Tan BC, Smith A, Groschup MH, Hunter N, Hornsey VS, MacGregor IR, et al. All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD. PLoS One. 2011;6(8):e23169. doi:10.1371/journal.pone.0023169. PMID:21858015.
   PubMed Web of Science ®Google Scholar
• Max DT. The family that couldn't sleep. 1st ed New York: Portobello; 2007
   Google Scholar
• Montagna P. Fatal familial insomnia: a model disease in sleep physiopathology. Sleep Med Rev 2005;9(5):339–53. doi:10.1016/j.smrv.2005.02.001. PMID:16109494.
   PubMed Web of Science ®Google Scholar
• Parchi P, Castellani R, Cortelli P, Montagna P, Chen SG, Petersen RB, Manetto V, Vnencak-Jones CL, McLean MJ, Sheller JR, et al. Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann Neurol. 1995;38(1):21–29. doi:10.1002/ana.410380107. PMID:7611720.
   PubMed Web of Science ®Google Scholar
• Panegyres PK, Armari E. Therapies for human prion diseases. Am J Neurodegener Dis. 2013;2(3):176–86. PMID:24093082.
   PubMedGoogle Scholar
• Lugaresi E, Provini F. Agrypnia excitata: clinical features and pathophysiological implications. Sleep Med Rev. 2001;5(4):313–22. doi:10.1053/smrv.2001.0166. PMID:12530995.
   PubMed Web of Science ®Google Scholar
• Schenkein J, Montagna P. Self-management of fatal familial insomnia. Part 2: case report. MedGenMed. 2006;8(3):66. PMID:17406189.
   PubMedGoogle Scholar
• Tabernero C. Fatal Familial Insomnia: clinical, neuropathological, and genetic description of a Spanish family. J Neurol Neurosurg Psychiatry. 2000;68(6):774–77. doi:10.1136/jnnp.68.6.774. PMID:10811705.
   PubMed Web of Science ®Google Scholar
• Llorens F, Thüne K, Schmitz M, Ansoleaga B, Frau-Méndez MA, Cramm M, Tahir W, Gotzmann N, Berjaoui S, Carmona M, et al. Identification of new molecular alterations in fatal familial insomnia. Human Mol Genet. 2016;25 (12):2417–36. PMID:27056979.
   PubMed Web of Science ®Google Scholar
• Zhang B. Fatal familial insomnia: a middle-age-onset Chinese family kindred. Sleep Med. 2010;11(5):498–99. doi:10.1016/j.sleep.2009.11.005. PMID:20133192.
   PubMed Web of Science ®Google Scholar
• Sawada H, Oeda T, Umemura A, Tomita S, Kohsaka M, Park K, Yamamoto K, Sugiyama H. Baseline C-reactive protein levels and life prognosis in parkison disease. PLoS One. 2015;10(7):e0134118. doi:10.1371/journal.pone.0134118. PMID:26218286.
   PubMed Web of Science ®Google Scholar
• Guaraldi P, Calandra-Buonaura G, Terlizzi R, Montagna P, Lugaresi E, Tinuper P, Cortelli P, Provini F. Oneiric stupor: the peculiar behaviour of agrypnia excitata. Sleep Med. 2011;12:S64–67. doi:10.1016/j.sleep.2011.10.014. PMID:22136903.
   PubMed Web of Science ®Google Scholar
• Benito-León J. Combined quinacrine and chlorpromazine therapy in fatal familial insomnia. J Neuropharmacol. 2004;27(4):201–03. doi:10.1097/01.wnf.0000134853.36429.0e.
   Google Scholar
• Gayrard V, Picard-Hagen N, Viguié C, Laroute V, Andréoletti O, Toutain PL. A possible pharmacological explanation for quinacrine failure to treat prion diseases: pharmacokinetic investigations in a ovine model of scrapie. Br J Pharmacol. 2005;144(3):386–93. doi:10.1038/sj.bjp.0706072. PMID:15655516.
   PubMed Web of Science ®Google Scholar
• Huang Y, Okochi H, May BC, Legname G, Prusiner SB, Benet LZ, Guglielmo BJ, Lin ET. Quinacrine is mainly metabolized to mono-desethyl quinacrine by Cyp3a4/5 and its brain accumulation is limited by P-Glycoprotein. Drug Metab Dispos. 2006;34(7):1136–44. doi:10.1124/dmd.105.008664. PMID:16581945.
   PubMed Web of Science ®Google Scholar
• Ghaemmaghami S, Ahn M, Lessard P, Giles K, Legname G, DeArmond SJ, Prusiner SB. Continuous quinacrine treatment results in the formation of drug-resistant prions. PLoS Pathog. 2009;5(11):e1000673. doi:10.1371/journal.ppat.1000673. PMID:19956709.
   PubMed Web of Science ®Google Scholar
• Noack A, Noack S, Hoffmann A, Maalouf K, Buettner M, Couraud PO, Romero IA, Weksler B, Alms D, Römermann K, et al. Drug-induced trafficking of p-glycoprotein in human brain capillary endothelial cells as demonstrated by exposure to mitomycin C. PLoS One. 2014;9(2):e88154. doi:10.1371/journal.pone.0088154. PMID:24505408.
   PubMed Web of Science ®Google Scholar
• Klyubin I, Nicoll AJ, Khalili-Shirazi A, Farmer M, Canning S, Mably A, Linehan J, Brown A, Wakeling M, Brandner S, et al. Peripheral administration of a humanized anti-PrP antibody blocks alzheimer's disease αβ synaptotoxicity. J Neurosci. 2014;34(18):6140–45. doi:10.1523/JNEUROSCI.3526-13.2014. PMID:24790184.
   PubMed Web of Science ®Google Scholar
• Wieser HG, Schwarz U, Blättler T, Bernoulli C, Sitzler M, Stoeck K, Glatzel M. Serial EEG findings in sporadic and iatrogenic creutzfeldt-jakob disease. Clin Neurophysiol. 2004;115(11):2467–78. doi:10.1016/j.clinph.2004.05.032. PMID:15465434.
   PubMed Web of Science ®Google Scholar
• Mangé A, Nishida N, Milhavet O, McMahon HE, Casanova D, Lehmann S. Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures. J Virol. 2000;74(77):3135–40. doi:10.1128/JVI.74.7.3135-3140.2000. PMID:10708429.
   PubMed Web of Science ®Google Scholar
• Pocchiari M, Schmittinger S, Masullo C. Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters. J Gen Virol. 1987;68(Pt 1):219–23. doi:10.1099/0022-1317-68-1-219. PMID:2433387.
   PubMed Web of Science ®Google Scholar
• Rosengren LE, Persson LI. Chlorpromazine treatment of blood-brain barrier dysfunction. A quantitative and fluorescence microscopical study on small cerebral stab wounds in the rat. Acta Neuropathol. 1979;46(1-2):145–50. doi:10.1007/BF00684816. PMID:452855.
   PubMed Web of Science ®Google Scholar
• Yoshii K, Kobayashi K, Tsumuji M, Tani M, Shimada N, Chiba K. Identification of human cytochrome P450 isoforms involved in the 7-hydroxylation of chlorpromazine by human liver microsomes. Life Sci. 2000;67(2):175–84. doi:10.1016/S0024-3205(00)00613-5. PMID:10901285.
   PubMed Web of Science ®Google Scholar
• Molnár J, Szabo D, Mándi Y, Mucsi I, Fischer J, Varga A, König S, Motohashi N. Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds. Anticancer Res. 1998;18(4C):3033–38. PMID:9713505.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Yokoi T, Inoue K, Shimada N, Ohashi N, Kume T, Kamataki T. Oxidation of histamine H1 antagonist mequitazine is catalyzed by cytochrome P450 2D6 in human liver microsomes. Pharmacogenetics. 1996;6(5):449–57. doi:10.1097/00008571-199610000-00009. PMID:8946477.
   PubMedGoogle Scholar
• Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem. 2010;31(2):455–61. PMID:19499576.
   PubMed Web of Science ®Google Scholar
• MacKerell, Jr AD, et al. Atomistic models and force fields. Comput Biochem Biophys., Inc. New York: Taylor & Francis; 7–38, 2001
   Google Scholar
• Tabaee Damavandi P, et al. Master's Thesis. “Computational studies of falcipain-2 irreversible peptidomimetic inhibitors”; 2010
   Google Scholar
• Tabaee Damavandi P, et al. Doctoral Thesis. “Novel applications of vibrational dynamics in the study of protein misfolding and neurodegenerative disorders”, Queen Mary University of London; 2016
   Google Scholar
• Widiger, Alexander H Jr. assignor to The Dow Chemical Company, Midland, Mich., “PREPARATION OF PHENOTHIAZINE” a corporation of Michigan No Drawing. Application February 27, 1942, Serial No. 432,641. ( Patented Oct. 10, 1944)
   Google Scholar
• Blase, JL, Cracco L, Schonberger LB, Maddox RA, Cohen Y, Cali I, Belay ED. Sporadic fatal insomnia in an adolescent. Pediatrics. 2014;133(3):e766–e770. doi:10.1542/peds.2013-1396. PMID:24488737.
   PubMed Web of Science ®Google Scholar